NCR2 and metabolic dysfunction-associated steatohepatitis: However, in contrast to the patients with NASH, HCV+ patients showed a significant accumulation of NKp44+ CD3−CD56+ cells in the liver, compared with their blood samples (P < 0.0001, median 13.5%; Figure 1B).